Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Interventional × Lymphoma × Patient Navigation × Clear all

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Plasma cell 1 Lymphoid 1

Conditions

Colorectal Neoplasms 11 Lung Neoplasms 8 Breast Neoplasms 8 Neoplasms 7 Uterine Cervical Neoplasms 6 Prostatic Neoplasms 2 Precursor Cell Lymphoblastic Leukemia-Lymphoma 2 Patient Compliance 2 Papillomavirus Infections 2 Liver Neoplasms 2 Hematopoietic and Lymphatic System Neoplasm 2 Colorectal Cancer Screening 2 Colonic Neoplasms 2 Carcinoma, Hepatocellular 2 Tobacco Use 1 Smoking 1 Rectal Neoplasms 1 Psychological Well-Being 1 Overweight 1 Obesity 1 Neoplasm Metastasis 1 Multiple Myeloma 1 Multiple Endocrine Neoplasia Type 1 1 Lymphoma 1 Liver Diseases 1 Hypertension 1 Hepatitis C 1 Hematologic Neoplasms 1 Head and Neck Neoplasms 1 HER2+ Metastatic Breast Cancer (MBC) 1

Interventions

Cyclophosphamide 378 Rituximab 325 Etoposide 189 Vincristine 174 Filgrastim 171 Doxorubicin 167 Prednisone 141 Radiotherapy 135 Cytarabine 132 fludarabine phosphate 119 Methotrexate 109 Melphalan 109 Peripheral Blood Stem Cell Transplantation 106 fludarabine 99 Busulfan 83 Dexamethasone 74 Carmustine 63 Granulocyte Colony-Stimulating Factor 60 Tacrolimus 58 Gemcitabine 56 Mycophenolic Acid 55 Whole-Body Irradiation 54 Bendamustine Hydrochloride 54 Antilymphocyte Serum 54 Cyclosporine 51 Lenalidomide 50 Ifosfamide 50 Bortezomib 48 Methylprednisolone 42 Leucovorin 39

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT06063603 2025-09-18

ASCENT

Mayo Clinic

Phase NA Completed

51 enrolled 8 charts

LymphoidPlasma cell

Lymphoma, Multiple Myeloma

Data powered by HemOnc (CC BY 4.0) Colophon ⚡